The OHSU Knight Cancer Institute’s Community Partnership Program funds four community-led projects designed to address cancer-related needs of underserved communities across the state.

Research led by Craig Newgard, M.D., finds substantial improvement in the survival of children treated in emergency departments nationwide that have adopted national pediatric care readiness standards

Jennifer Mensik Kennedy, Ph.D., M.B.A., RN, says her priorities as the new American Nurses Association president include safe staffing and fighting racism; about nurse staffing she says: “This has been an issue well beyond COVID. COVID exacerbated it and shined a light on some of these issues, but this has been going on for some time. We need to focus on solving this one because it has a lot of impact on patient safety. This has an impact for nurses staying in the workforce."

Beaverton child Raiden Pham has a rare genetic disorder, and efforts led by OHSU Ruth Napier, Ph.D., to develop a gene therapy through the Raiden Science Foundation.

News briefing held by Oregon Health Authority cites Jan. 6 statewide forecast by Peter Graven, Ph.D., predicting a small increase in the number of people hospitalized with COVID-19 due to the XBB.1.5 variant.

Research led by Craig Newgard, M.D., finds substantial improvement in the survival of children treated in emergency departments nationwide that have adopted national pediatric care readiness standards.

New research led by Eric Simpson, M.D., revealing adults and adolescents with moderate to severe atopic dermatitis showed significant improvements with the addition of lebrikizumab to topical steroid therapy compared to TCS plus placebo.

OHSU and Oregon State University researchers are developing a new approach to gene therapy for inherited forms of blindness that uses lipid nanoparticles to deliver gene-altering mRNA. Renee Ryals, Ph.D., says: “Improving the technologies used for gene therapy can provide more treatment options to prevent blindness. Our study’s findings show that lipid nanoparticles could help us do just that.”

OHSU and Oregon State University researchers are developing a new approach to gene therapy for inherited forms of blindness that uses lipid nanoparticles to deliver gene-altering mRNA. Renee Ryals, Ph.D., says: “Improving the technologies used for gene therapy can provide more treatment options to prevent blindness. Our study’s findings show that lipid nanoparticles could help us do just that.”

OHSU and Oregon State University researchers are developing a new approach to gene therapy for inherited forms of blindness that uses lipid nanoparticles to deliver gene-altering mRNA. Renee Ryals, Ph.D., says: “Improving the technologies used for gene therapy can provide more treatment options to prevent blindness. Our study’s findings show that lipid nanoparticles could help us do just that.”